- Home
- GPCR vs NVRI Comparison
GPCR vs NVRI Comparison
Compare GPCR & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- NVRI
- Stock Information
- Founded
- GPCR 2016
- NVRI 1853
- Country
- GPCR United States
- NVRI United States
- Employees
- GPCR N/A
- NVRI N/A
- Industry
- GPCR
- NVRI Diversified Commercial Services
- Sector
- GPCR
- NVRI Miscellaneous
- Exchange
- GPCR Nasdaq
- NVRI Nasdaq
- Market Cap
- GPCR 1.1B
- NVRI 911.3M
- IPO Year
- GPCR 2023
- NVRI N/A
- Fundamental
- Price
- GPCR $20.91
- NVRI $12.20
- Analyst Decision
- GPCR Strong Buy
- NVRI Hold
- Analyst Count
- GPCR 9
- NVRI 1
- Target Price
- GPCR $75.63
- NVRI $10.00
- AVG Volume (30 Days)
- GPCR 1.1M
- NVRI 1.3M
- Earning Date
- GPCR 08-06-2025
- NVRI 10-30-2025
- Dividend Yield
- GPCR N/A
- NVRI N/A
- EPS Growth
- GPCR N/A
- NVRI N/A
- EPS
- GPCR N/A
- NVRI N/A
- Revenue
- GPCR N/A
- NVRI $2,242,873,000.00
- Revenue This Year
- GPCR N/A
- NVRI N/A
- Revenue Next Year
- GPCR N/A
- NVRI $3.72
- P/E Ratio
- GPCR N/A
- NVRI N/A
- Revenue Growth
- GPCR N/A
- NVRI N/A
- 52 Week Low
- GPCR $13.22
- NVRI $4.72
- 52 Week High
- GPCR $45.37
- NVRI $12.40
- Technical
- Relative Strength Index (RSI)
- GPCR 58.61
- NVRI 73.42
- Support Level
- GPCR $18.49
- NVRI $11.43
- Resistance Level
- GPCR $22.25
- NVRI $11.97
- Average True Range (ATR)
- GPCR 1.16
- NVRI 0.40
- MACD
- GPCR 0.15
- NVRI 0.05
- Stochastic Oscillator
- GPCR 66.38
- NVRI 87.11
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.